These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27824415)

  • 1. [Atrial fibrillation: therapy gets more and more individualized].
    Marx N
    Dtsch Med Wochenschr; 2016 Oct; 141(22):1610. PubMed ID: 27824415
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug therapy in atrial fibrillation].
    Schuchert A
    Herzschrittmacherther Elektrophysiol; 2014 Mar; 25(1):1-2. PubMed ID: 24525719
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of atrial fibrillation: recommendations from NICE.
    Lim WY; Khan F
    Br J Hosp Med (Lond); 2015 Jul; 76(7):C108-12. PubMed ID: 26140571
    [No Abstract]   [Full Text] [Related]  

  • 4. [Risk of thromboembolism in atrial fibrillation].
    Csanádi Z
    Orv Hetil; 2016 Sep; 157(38):1511-5. PubMed ID: 27640617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Educational Needs of Clinicians Regarding Anticoagulation Therapy for Prevention of Thromboembolism and Stroke in Patients With Atrial Fibrillation.
    Glauser TA; Barnes J; Nevins H; Cerenzia W
    Am J Med Qual; 2016; 31(1):38-46. PubMed ID: 25115364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic management of non-valvular atrial fibrillation. Update 2013].
    Bode K; Sommer P; Bollmann A; Hindricks G
    Herz; 2013 Nov; 38(7):743-55; quiz 756-7. PubMed ID: 24065049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interventions in atrial fibrillation. Non-pharmacological rhythm control and stroke prevention].
    Israel CW
    Herzschrittmacherther Elektrophysiol; 2013 Mar; 24(1):1. PubMed ID: 23604532
    [No Abstract]   [Full Text] [Related]  

  • 10. [Stroke prevention].
    Bergmann MW; Kuck KH
    Herz; 2013 May; 38(3):229-30. PubMed ID: 23588604
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolving strategies to prevent stroke and thromboembolism in nonvalvular atrial fibrillation.
    Hussein A; Saliba W; Wazni OM
    Cleve Clin J Med; 2015 Dec; 82(12 Suppl 2):S11-6. PubMed ID: 26694887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atrial fibrillation and stroke].
    Mattle HP; Schwerzmann M; Seiler Ch
    Ther Umsch; 2003 Sep; 60(9):527-34. PubMed ID: 14579621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulants in heart disease.
    Vine DL
    Kans Med; 1991 Apr; 92(4):114, 112. PubMed ID: 1881021
    [No Abstract]   [Full Text] [Related]  

  • 14. Stroke prevention in atrial fibrillation.
    Mohammed I; Mohmand-Borkowski A; Burke JF; Kowey PR
    J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):73-85. PubMed ID: 22193836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct thrombin inhibitors: novel antithrombotics on the horizon in the thromboprophylactic management of atrial fibrillation.
    Katira R; Chauhan A; More RS
    Postgrad Med J; 2005 Jun; 81(956):370-5. PubMed ID: 15937202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation.
    Lip GY; Tse HF; Lane DA
    Lancet; 2012 Feb; 379(9816):648-61. PubMed ID: 22166900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.
    Singer DE; Fang MC; Go AS
    Arch Intern Med; 2009 Nov; 169(21):2032; author reply 2033. PubMed ID: 19933969
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined anticoagulation and antiplatelet therapy in AF patients: why do we not follow guidelines?
    Brandes A
    Heart; 2014 Oct; 100(20):1565-6. PubMed ID: 25143367
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticoagulation for atrial fibrillation: underuse?
    Pechlaner C
    Am J Med; 2011 Jul; 124(7):e11; author reply e13. PubMed ID: 21683818
    [No Abstract]   [Full Text] [Related]  

  • 20. Stroke and major bleeding risk in elderly patients aged ≥75 years with atrial fibrillation: the Loire Valley atrial fibrillation project.
    Lip GY; Clementy N; Pericart L; Banerjee A; Fauchier L
    Stroke; 2015 Jan; 46(1):143-50. PubMed ID: 25424474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.